Loading stock data…
SSII
$3.36-0.17 (-4.82%)
Market ClosedLast close Jun 12
SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
SS Innovations International, Inc. in the Healthcare sector is trading at $3.36 with a market capitalization of $863M. Wall Street consensus targets $7.00 (1 analysts), implying a +108.3% move over the next 12 months. The stock is currently near its 52-week low of $3.02, remaining 38.7% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +108.3% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $11.10M↓ | $14.53M↑ | $12.83M↑ | $10.00M↑ | $5.12M |
| Gross Profit | $5.33M↓ | $6.38M↑ | $6.16M↑ | $5.92M↑ | $1.09M |
| Operating Income | -$3.64M↓ | -$734,997↑ | -$1.84M↓ | $97,014↑ | -$5.92M |
| Net Income | -$3.58M↓ | -$2.47M↑ | -$3.72M↓ | -$256,691↑ | -$5.68M |
Peer Comparison
JNJUNHPFE
Fundamentals
SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$862.57M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-18.39%
Volume
Today's trading volume
40,659
Recent News
SS Innovations International Insiders Placed Bullish Bets Worth US$5.20m
Over the last year, a good number of insiders have significantly increased their holdings in SS Innovations...
SS Innovations International, Inc. (SSII) Gains Approvals for SSi Mantra in Key Emerging Markets
We recently compiled a list of the 12 Penny Stocks with Insider Buying in 2026. SS Innovations International, Inc. is one of the best stocks with Insider buying on this list. TheFly reported on March 30 that SSII announced that its SSi Mantra surgical robotic system obtained regulatory approvals for multiple uses in Colombia, Oman, […]
SS Innovations ramps up in telesurgery; XCath robot treats stroke remotely
SS Innovations’ robot won approvals to perform telesurgery in Indonesia and the Philippines, while the first remote robotic mechanical thrombectomy to treat stroke was performed with XCath’s system.
Why SS Innovations (SSII) Is Up 10.8% After Telesurgery Milestone And Auditor Going Concern Doubts
SS Innovations International, Inc. recently reported that for the fourth quarter of 2025 its revenue rose to US$14.53 million while it recorded a net loss of US$2.47 million, and full-year 2025 revenue increased to US$42.48 million with a reduced net loss of US$12.13 million, although its auditor raised going concern doubts in the latest 10-K. Around the same time, the company announced that its SSi Mantra surgical robotic system has been cleared for telesurgeries in Indonesia and the...
SS Innovations raises $18.6M as surgical robot nears US market
Intuitive co-founder Fred Moll invested $2 million, supporting SS Innovations’ efforts to launch its robot in the U.S.